Objective To investigate the neuroprotection of Venlafaxine and its mechanism.
目的：探讨万拉法新的神经保护作用及其机制。
To explore the predictors of treatment effect in depression taking venlafaxine.
文拉法辛抗抑郁疗效预测及起效过程分析。
Generic venlafaxine hydrochloride will have the same safety warnings as Effexor XR.
盐酸文拉法辛与原研药有相同的安全警告。
Objective To study the efficacy of venlafaxine in the treatment of Post-stroke depression (PSD).
目的探讨万拉法新治疗脑卒中后抑郁状态的疗效。
Conclusion: Venlafaxine is effective for treatment of post stroke depression with less side effects.
结论：万拉法新治疗脑卒中后抑郁症疗效明显、副作用较少。
Conclusion: Both paroxetine and venlafaxine are efficacious to treat depression with and without delusion.
结论：帕罗西汀和文拉法辛治疗妄想性抑郁症和非妄想性抑郁症均有效。
ObjectiveTo explore the effect of calligraphy training plus venlafaxine in the treatment of anxiety disorder.
目的探讨书法训练配合博乐欣治疗焦虑症的疗效。
Objective To compare the efficacy of Venlafaxine and Buspirone in treating depression associated with anxiety.
目的比较万拉法新与丁螺环酮治疗伴有焦虑症状的抑郁症的疗效。
Conclusion Venlafaxine has better efficacy, higher safety and compliance in the treatment of generalized anxiety.
结论怡诺思治疗广泛性焦虑疗效肯定，安全性高，依从性好。
This study analyzes the methods, efficacy and adverse drug reactions (ADR) of domestic literatures on venlafaxine.
本文对该药的使用方法、临床疗效、不良反应等进行汇总分析。
The questionnaire results show that the most widely used antidepressants are paroxetine, fluoxetine and venlafaxine.
结果显示目前排名抗抑郁药物使用率前三位的分别是帕罗西汀，氟西汀及文拉法辛；
Objective: To compare the clinical efficacy and safety of venlafaxine with maprotiline in the treatment of depression.
目的：比较文拉法辛与马普替林治疗抑郁症的疗效及安全性。
AIM: To observe the efficacy and safety of venlafaxine capsules in the treatment of the chronic tension-type headache.
目的：观察文拉法辛胶囊治疗慢性紧张型头痛的有效性及安全性。
And the abnormal activation of prefrontal lobe. left insular and thalamus can be regulated after venlafaxine treatment.
文拉法辛对前额叶、左侧岛叶和丘脑的异常激活有调节作用。
AIM: To compare the effects, adverse reactions and emotion change of venlafaxine vs furazolidone for harmful alcoholics.
目的：比较文拉法辛与呋喃唑酮对有害饮酒治疗的疗效、不良反应以及治疗过程中的心境变化。
Objective To explore the curative effects and safety of venlafaxine and clomipramine in anxiety and depression comorbidity.
目的探讨万拉法新与氯米帕明治疗焦虑抑郁障碍共病的疗效及安全性。
Conclusion venlafaxine combined with vitamin B6 is better than single venlafaxine in the maintenance therapy of depression.
结论万拉法新联合维生素B6维持治疗抑郁症较单用万拉发新疗效显著。
Objective: To compare the efficacy and safety of venlafaxine capsules and paroxetine tablets in the treatment of depression.
目的：比较万拉法新与帕罗西汀治疗抑郁症的疗效和安全性。
Objective To explore the adjunctive therapeutic action of vitamin B6 to venlafaxine in the maintenance therapy of depression.
目的探讨维生素B6在万拉法新维持治疗抑郁症中的辅助治疗作用。
Objective To study the clinical efficacy and side effect of venlafaxine in the treatment of generalized anxiety disorder (GAD).
目的评价文拉法辛治疗广泛性焦虑症的临床疗效和副作用。
ObjectiveTo investigate the effect of Tongxinluo capsule combined venlafaxine in the treatment of depression after cerebral infarction.
目的探讨通心络胶囊联合文拉法辛治疗脑梗死后抑郁的临床疗效。
Objective To compare the difference in full remission rate of depression patients treated with venlafaxine and tricyclic antidepressants.
目的比较文拉法辛与三环抗抑郁药治疗抑郁症临床痊愈率的差异。
Objective To compare the difference in rate of side effects of depression patients treated with venlafaxine and tricyclic antidepressants.
目的比较文拉法辛与三环类抗抑郁药物治疗抑郁症临床副作用的差异。
Objective: To compare the efficacy and safety of treatment of female depression disorder between Venlafaxine Sustained-Release and Citalopram.
目的：比较文拉法新缓释片与西酞普兰治疗女性抑郁症的疗效与安全性。
Objective to study the protective effects of antipsychotic drugs Venlafaxine and Olanzapine on pheochromocytoma (PC12) cells after serum withdrawal.
目的：研究抗精神失常药万拉法辛和奥氮平对撤掉血清诱发PC 12细胞损伤的神经保护作用。
Results: The efficacy of Venlafaxine versus Amitriptyline were much similar. But side effects in Venlafaxine group were smaller than that in Amitriptyine.
结果：博乐欣的疗效和起效时间与阿米替林相当，其抗胆碱能不良反应小于阿米替林。
The patients were receiving mood stabilizers, had moderate to severe depression, and participated in a 10-week trial of sertraline, venlafaxine, or bupropion.
患者当时正在接受心境稳定剂治疗的。他们有中度到重度的抑郁，同时还参与了10周的舍曲林、文拉法辛或是安非他酮的实验。
Conclusion Venlafaxine has significant curative effect, better compliance, milder adverse reactions and higher safety, and deserves to be popularized clinically.
结论万拉法新是一种治疗老年期抑郁症疗效显著、依从性好、不良反应较轻、安全性好的抗抑郁剂，值得临床推广。
Conclusion Antidepressant venlafaxine and fluoxetine both have certain neuroprotection, however, venlafaxine has greater neuroprotection compared with fluoxetine.
结论：抗抑郁药万拉法新和氟西汀都具有一定的神经保护作用，且万拉法新神经保护作用强于氟西汀。
CONCLUSION: Adverse reaction of venlafaxine on harmful alcoholics is smaller than furazolidone and the effect of venlafaxine on alcoholics is better than furazolidone.
结论：文拉法辛治疗有害饮酒不良反应少于呋喃唑酮，治疗有效率高于呋喃唑酮。
应用推荐